Use of viral protein as therapeutic agent other than vaccine

Follow

Industry

CPC
C12N2710/24233

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12NMICRO-ORGANISMS OR ENZYMES COMPOSITIONS THEREOF PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS MUTATION OR GENETIC ENGINEERING CULTURE MEDIA C12N2710/00dsDNA Viruses

Current Industry

C12N2710/24233Use of viral protein as therapeutic agent other than vaccine

Industries

Patents Grantslast 30 patents

Information Patent Grant
Use of Parapox B2L protein to treat cancer and modify immune responses
- Patent number 6,844,000
- Issue date Jan 18, 2005
- Bayer Pharmaceuticals Corporation
- Delanie Cassell
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
Use of Parapox B2L protein to treat cancer and modify immune responses
- Publication number 20030109483
- Publication date Jun 12, 2003
- Delanie Cassell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE